Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,266 public trials 444 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)

NCT04490499

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0009) Kokkola, Keski-Pohjanmaa, Finland
  • Tampereen yliopisto Oulun rokotetutkimusklinikka ( Site 0004) Oulu, North Ostrobothnia, Finland
  • Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001) Tampere, Pirkanmaa, Finland
  • Seinajoki Vaccine Research Center ( Site 0010) Seinajoki, Pohjanmaa, Finland
View Trial Details
Completed

Cameroon HepB Birth Dose Feasibility Pilot

NCT04893616

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • CMA Dibi Dibi, Adamaoua Region, Cameroon
  • CMA Mbe Mbé, Adamawe, Cameroon
  • HD Biyem-Assi Biyem Assi, Center, Cameroon
  • HD Cite Verte Cite Verte, Center, Cameroon
View all 13 locations
View Trial Details
Completed

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

NCT01058512

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Borland-Grooover Clinic Jacksonville, Florida, United States
  • Venture Research Institute, LLC Miami, Florida, United States
  • Orlando Immunology Center Orlando, Florida, United States
  • MetroWest Medical Center Framingham, Massachusetts, United States
View Trial Details
Completed

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

NCT02833844

Conditions
Behavior, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Hartford, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 78 locations
View Trial Details

Related conditions